WebIn terms of dividends, Ionis Pharmaceuticals Inc has a dividend per share of 0 and a dividend yield of 0. The company's most recent dividend date was None, and the ex-dividend date was None. IONS's financials reveal a book value of 4.033 and earnings per share (EPS) of -1.88, with a diluted EPS (TTM) of -1.88. Web31 mrt. 2024 · Company. Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily …
Ionis Pharmaceuticals - IONS - Stock Price & News The Motley …
Web7 apr. 2024 · Ionis Pharmaceuticals Inc’s stock is NA in 2024, NA in the previous five trading days and down 2.61% in the past year. Currently, Ionis Pharmaceuticals Inc does not have a price-earnings ratio. Ionis Pharmaceuticals Inc’s trailing 12-month revenue is $587.4 million with a -45.9% net profit margin. WebThe latest closing stock price for Ionis Pharmaceuticals as of April 06, 2024 is 37.27. The all-time high Ionis Pharmaceuticals stock closing price was 86.14 on April 08, 2024. The Ionis Pharmaceuticals 52-week high stock price is 48.82, which is … income tax in us virgin islands
IONIS PHARMACEUTICALS, INC. : IONS Stock Price
WebIONIS PHARMACEUTICALS, INC. : IONS Stock Price US4622221004 MarketScreener Homepage Equities Switzerland Berne Stock Exchange Ionis Pharmaceuticals, Inc. … Web31 mrt. 2024 · Alkermes currently has a consensus price target of $30.75, indicating a potential upside of 2.91%. Ionis Pharmaceuticals has a consensus price target of $45.33, indicating a potential upside of 20.70%. Given Ionis Pharmaceuticals' higher probable upside, analysts clearly believe Ionis Pharmaceuticals is more favorable than Alkermes. Web1 dag geleden · The analyst notes that Arrowhead stock lost around 35% YTD, underperforming the peers such as Alnylam Pharmaceuticals, Inc ALNY, Ionis Pharmaceuticals Inc IONS, and Moderna Inc MRNA. income tax in union budget 2021